Heart · 1980 · 166 citations · 25 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyClinical CardiologyClinical PharmacologyCardiac Risk AssessmentClinical TrialsCoronary Artery DiseaseHeart FailureIschemic Heart DiseaseMyocardial Infarction ComplicationsCardiovascular Outcome TrialsMyocardial Infarction PharmacotherapyPlacebo-controlled Efficacy AssessmentPost-myocardial Infarction PharmacotherapyPrognostic Factors AnalysisPrognostic Risk AssessmentPrognostic Subgroup AnalysisPropranolol Therapy
A multicentre study of survivors of an anterior myocardial infarction is reported. The trial consisted of 720 patients and was a double-blind, placebo-controlled study with propranolol 40 mg three times a day. Trial entry was at two to 14 days (mean 8.5 days) and follow-up at one, three, and in most centres, six and nine months. The trial was designed to detect a 50 per cent reduction in mortality and this was not shown. The non-fatal reinfarction rate was similar in both groups. Subgroup analysis identified several prognostic risk factors for death, none of which interacted with treatment.
25
Technometrics · 2005 · 18.1K citations
Business, Biostatistics, Mathematics +17
Lee J. Bain, N. H. Draper, H. Smith · Technometrics · 1967 · 3.3K citations
REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTION BY TREATMENT WITH ALPRENOLOL
Claes Wilhelmsson, Lars Wilhelmsen, J. A. Vedin et al. · The Lancet · 1974 · 462 citations